The court requested additional briefing on the harm sustained by one of the plaintiffs, disabled U.S. Air Force veteran Michael Krawitz,
On October 16, 2012 the D.C. Circuit heard oral arguments in Americans for Safe Access v. Drug Enforcement Administration, a legal challenge to the government’s contention that cannabis has no medical use. ASA argues that the DEA acted improperly in denying a petition to reclassify cannabis as having medical use. The panel of three judges focused on whether ASA has a legal basis for suing the government.
As many know… and the Americans for Safe Access appeal states, the feds have acted indiscriminately and impulsively in rejecting the claim that marijuana can be a benefit to millions of sick and dying patients all over the U.S. The ASA further disputes in its arguments that the Federal government and the DEA have absolutely no “Authority to apply dissimilar standards to marijuana studies than to any other drugs, discount critical research data, pervert social science research, rely upon uncorroborated suppositions… as the DEA has done – and continues to do.”
The court requested additional briefing on the harm sustained by one of the plaintiffs, disabled U.S. Air Force veteran Michael Krawitz, who was denied treatment by the VA because he was using cannabis on a doctor’s advice. The case is the first time in nearly 20 years that a federal court has heard arguments on the classification of cannabis as a Schedule I substance. A decision on whether the suit can proceed is expected soon.
Mr. Krawitz is a 49-year-old resident of Elliston, Virginia, who suffered an automobile accident in 1984 while serving in the United States Air Force. Mr. Krawitz has been rated by the United States Department of Veterans Affairs (VA) as being totally and permanently disabled. Mr. Krawitz uses marijuana to treat chronic pain and trauma associated with his accident. He also use marijuana to treat central serous retinopathy. However, because of Mr. Krawitz’s medical marijuana use, he has been denied pain treatment by the VA
Source – ASA